D. Martin Watterson
Department of Molecular Pharmacology and Biological Chemistry
Northwestern University Medical School
Chicago IL 60611-3008
USA
Name/email consistency: high
- Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against beta-amyloid induced injury: a foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progression. Watterson, D.M., Velentza, A.V., Zasadzki, M., Craft, J.M., Haiech, J., Van Eldik, L.J. J. Mol. Neurosci. (2003)
- Discovery of new chemical classes of synthetic ligands that suppress neuroinflammatory responses. Watterson, D.M., Haiech, J., Van Eldik, L.J. J. Mol. Neurosci. (2002)
- Ligand modulation of glial activation: cell permeable, small molecule inhibitors of serine-threonine protein kinases can block induction of interleukin 1 beta and nitric oxide synthase II. Watterson, D.M., Mirzoeva, S., Guo, L., Whyte, A., Bourguignon, J.J., Hibert, M., Haiech, J., Van Eldik, L.J. Neurochem. Int. (2001)